{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T19:06:17Z","timestamp":1788548777139,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s10147-023-02399-7","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T08:03:31Z","timestamp":1691481811000},"page":"1520-1529","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effect of duration of adjuvant chemotherapy with S-1 (6 versus 12\u00a0months) for resected pancreatic cancer: the multicenter clinical randomized phase II postoperative adjuvant chemotherapy S-1 (PACS-1) trial"],"prefix":"10.1007","volume":"28","author":[{"given":"Hiroto","family":"Kayashima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0382-2520","authenticated-orcid":false,"given":"Shinji","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mototsugu","family":"Shimokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Takamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Fukuzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Ninomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yo-ichi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishi","family":"Sugimachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Morine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Utsunomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Uwagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoharu","family":"Yoshizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,8]]},"reference":[{"key":"2399_CR1","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1186\/s12885-022-10116-2","volume":"22","author":"K Kobayashi","year":"2022","unstructured":"Kobayashi K, Einama T, Takihata Y et al (2022) Therapeutic efficacy of dose-reduced adjuvant chemotherapy with S-1 in patients with pancreatic cancer: a retrospective study. BMC Cancer 22:1028","journal-title":"BMC Cancer"},{"key":"2399_CR2","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.pan.2021.08.003","volume":"21","author":"S Itoh","year":"2021","unstructured":"Itoh S, Tsujita E, Fukuzawa K et al (2021) Prognostic significance of preoperative PNI and CA19-9 for pancreatic ductal adenocarcinoma: a multi-institutional retrospective study. Pancreatology 21:1356\u20131363","journal-title":"Pancreatology"},{"key":"2399_CR3","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1200\/JCO.2006.09.2551","volume":"25","author":"A Sultana","year":"2007","unstructured":"Sultana A, Smith CT, Cunningham D et al (2007) Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses. J Clin Oncol 25:2607\u20132615","journal-title":"J Clin Oncol"},{"key":"2399_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s002689900215","volume":"21","author":"C Sperti","year":"1997","unstructured":"Sperti C, Pasquali C, Piccoli A et al (1997) Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg 21:195\u2013200","journal-title":"World J Surg"},{"key":"2399_CR5","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1097\/00000658-199912000-00006","volume":"230","author":"JH Klinkenbijl","year":"1999","unstructured":"Klinkenbijl JH, Jeekel J, Sahmoud T et al (1999) Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 230:776\u2013782","journal-title":"Ann Surg"},{"key":"2399_CR6","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1056\/NEJMoa032295","volume":"350","author":"JP Neoptolemos","year":"2004","unstructured":"Neoptolemos JP, Stocken DD, Friess H et al (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350:1200\u20131210","journal-title":"N Engl J Med"},{"key":"2399_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1001\/jama.297.3.267","volume":"297","author":"H Oettle","year":"2007","unstructured":"Oettle H, Post S, Neuhaus P et al (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297:267\u2013277","journal-title":"JAMA"},{"key":"2399_CR8","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","volume":"379","author":"T Conroy","year":"2018","unstructured":"Conroy T, Hammel P, Hebbar M et al (2018) FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer. N Engl J Med 379:2395\u20132406","journal-title":"N Engl J Med"},{"key":"2399_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0140-6736(16)30583-9","volume":"388","author":"K Uesaka","year":"2016","unstructured":"Uesaka K, Boku N, Fukutomi A et al (2016) Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). Lancet 388:248\u2013257","journal-title":"Lancet"},{"key":"2399_CR10","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1056\/NEJMoa072252","volume":"357","author":"S Sakuramoto","year":"2007","unstructured":"Sakuramoto S, Sasako M, Yamaguchi T et al (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357:1810\u20131820","journal-title":"N Engl J Med"},{"key":"2399_CR11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S2468-1253(18)30383-2","volume":"4","author":"T Yoshikawa","year":"2019","unstructured":"Yoshikawa T, Terashima M, Mizusawa J et al (2019) Four courses versus eight courses of adjuvant S-1 for patients with stage II gastric cancer (JCOG1104 [OPAS-1]): an open-label, phase 3, non-inferiority, randomized trial. Lancet Gastroenterol Hepatol 4:208\u2013216","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2399_CR12","volume-title":"General rules for the study of pancreatic cancer","author":"Japanese Pancreas Society","year":"2009","unstructured":"Japanese Pancreas Society (2009) General rules for the study of pancreatic cancer, 6th edn. Kanehara, Tokyo","edition":"6"},{"key":"2399_CR13","volume-title":"TNM classification of malignant tumours","author":"LH Sobin","year":"2009","unstructured":"Sobin LH, Gospodarowicz MK, Wittekind C (2009) TNM classification of malignant tumours, 7th edn. Wiley-Blackwell, Hoboken","edition":"7"},{"key":"2399_CR14","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649\u2013655","journal-title":"Am J Clin Oncol"},{"key":"2399_CR15","unstructured":"Common Terminology Criteria for Adverse Events v4.0 (CTCAE). http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm#ctc_40"},{"key":"2399_CR16","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/cncr.34580","volume":"129","author":"Y Tomimaru","year":"2023","unstructured":"Tomimaru Y, Eguchi H, Inoue Y et al (2023) Impact of S-1 adjuvant chemotherapy longer than 6 months on survival in patients with resected pancreatic cancer: a nationwide survey by the Japan Pancreas Society based on real-world data. Cancer 129:728\u2013739","journal-title":"Cancer"},{"key":"2399_CR17","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1200\/JCO.2013.50.7657","volume":"32","author":"JW Valle","year":"2014","unstructured":"Valle JW, Palmer D, Jackson R et al (2014) Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. J Clin Oncol 32:504\u2013512","journal-title":"J Clin Oncol"},{"key":"2399_CR18","doi-asserted-by":"publisher","first-page":"e4282","DOI":"10.1097\/MD.0000000000004282","volume":"95","author":"N Yabusaki","year":"2016","unstructured":"Yabusaki N, Fujii T, Yamada S et al (2016) The significance of relative dose intensity in adjuvant chemotherapy of pancreatic ductal adenocarcinoma including the analysis of clinicopathological factors influencing relative dose intensity. Medicine (Baltimore) 95:e4282","journal-title":"Medicine (Baltimore)"},{"key":"2399_CR19","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/sj.bjc.6602804","volume":"93","author":"M Tsukuda","year":"2005","unstructured":"Tsukuda M, Kida A, Fujii M et al (2005) Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer. Br J Cancer 93:884\u2013889","journal-title":"Br J Cancer"},{"key":"2399_CR20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10147-004-0381-9","volume":"9","author":"W Arai","year":"2004","unstructured":"Arai W, Hosoya Y, Hyodo M et al (2004) Alternate-day oral therapy with TS-1 for advanced gastric cancer. Int J Clin Oncol 9:143\u2013148","journal-title":"Int J Clin Oncol"},{"key":"2399_CR21","first-page":"1455","volume":"26","author":"Y Rino","year":"2006","unstructured":"Rino Y, Takanashi Y, Yukawa N et al (2006) A phase I study of bi-weekly combination therapy with S-1 and docetaxel for advanced or recurrent gastric cancer. Anticancer Res 26:1455\u20131462","journal-title":"Anticancer Res"},{"key":"2399_CR22","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1186\/s12885-021-08232-6","volume":"21","author":"N Okumura","year":"2021","unstructured":"Okumura N, Soh J, Suzuki H et al (2021) Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301. BMC Cancer 21:506","journal-title":"BMC Cancer"},{"key":"2399_CR23","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1007\/s10147-019-01465-3","volume":"24","author":"T Moriwaki","year":"2019","unstructured":"Moriwaki T, Sakai Y, Ishida H et al (2019) Phase II study of S-1 on alternate days plus bevacizumab in patients aged \u2265 75 years with metastatic colorectal cancer (J-SAVER). Int J Clin Oncol 24:1214\u20131222","journal-title":"Int J Clin Oncol"},{"key":"2399_CR24","doi-asserted-by":"publisher","first-page":"847","DOI":"10.18632\/oncotarget.26614","volume":"10","author":"T Ojima","year":"2019","unstructured":"Ojima T, Nakamura M, Nakamori M et al (2019) Triplet chemotherapy with docetaxel, cisplatin and S-1 for unresectable advanced squamous cell carcinoma of the esophagus: phase I\/II trial results. Oncotarget 10:847\u2013855","journal-title":"Oncotarget"},{"key":"2399_CR25","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1093\/jjco\/hyy190","volume":"49","author":"F Motoi","year":"2019","unstructured":"Motoi F, Kosuge T, Ueno H et al (2019) Randomized phase II\/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02\/JSAP05). Jpn J Clin Oncol 49:190\u2013194","journal-title":"Jpn J Clin Oncol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-023-02399-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-023-02399-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-023-02399-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T23:10:42Z","timestamp":1698707442000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-023-02399-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["2399"],"URL":"https:\/\/doi.org\/10.1007\/s10147-023-02399-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2939742\/v1","asserted-by":"object"}]},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,8]]},"assertion":[{"value":"15 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no conflicts of interest regarding this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by Kyushu University Hospital Institutional Review Board (Approval number: 25066). This trial was completed in accordance with the Declaration of Helsinki and the Ethical Guidelines for Clinical Studies of the Ministry of Health, Labour, and Welfare of Japan.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all patients for inclusion in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This study was registered at University hospital Medical Information Network (UMIN) Clinical Trials Registry as UMIN000012634 (\n                      \n                      ).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Registration number"}}]}}